Standard TRT doses of 100 to 200 mg per week of testosterone enanthate or cypionate are enough to build measurable muscle, with most men gaining lean mass within the first 12 to 16 weeks. The exact amount you gain depends less on the milligrams injected and more on where your testosterone levels land, how you train, and how you eat.
The Dose Range That Builds Muscle
Clinical TRT typically falls between 100 and 200 mg per week of injectable testosterone. A commonly studied protocol is 100 mg weekly or 200 mg every two weeks. Research comparing a range of doses from 25 mg to 600 mg per week found that 125 mg weekly offered the best balance of muscle-building benefit and minimal side effects. Higher doses of 300 and 600 mg per week produced more muscle but also a high rate of adverse effects, pushing them well beyond therapeutic territory into performance-enhancement ranges.
The goal of TRT isn’t to push testosterone as high as possible. It’s to bring levels into the normal range for healthy young men, which sits between roughly 264 and 916 ng/dL based on harmonized reference data from large cohort studies across the U.S. and Europe. Most prescribing clinicians aim for the mid-to-upper portion of that range, somewhere around 500 to 700 ng/dL. Where you land within that window matters more than the number of milligrams you inject, since individuals absorb and metabolize testosterone differently.
Why Free Testosterone Matters More
Total testosterone is the number most people track, but free testosterone is the fraction that actually reaches your muscle cells. As men age, a protein called sex hormone-binding globulin (SHBG) rises, which binds more testosterone and makes it unavailable for use. This means total testosterone can look acceptable on a lab report while free testosterone is actually quite low.
A pooled analysis of older men found that lean mass, muscle strength, power, and physical performance were all more strongly linked to free testosterone than to total testosterone. In men over 65, total testosterone showed no significant association with lean mass at all, while free testosterone did. If you’re on TRT and not seeing the body composition changes you expected, your free testosterone level is worth checking. It may explain a disconnect between your dose and your results.
How Much Muscle You Can Expect
If you’re starting TRT because of genuinely low testosterone, the initial changes in body composition are noticeable but not dramatic. One detailed case report tracking a hypogonadal man on TRT found a 6% increase in lean muscle mass during the first phase of treatment, followed by an additional 3.8% in the next phase. For a 180-pound man, that first jump would be roughly 5 to 7 pounds of lean tissue, depending on starting body fat.
Fat loss happens simultaneously. Studies consistently show a decrease in fat mass starting around three months, with continued improvement over 12 to 24 months. Waist circumference tends to drop, trunk fat declines, and the waist-to-hip ratio improves. The net effect on the scale can be misleading: total body weight sometimes stays flat or even drops slightly because you’re losing fat while gaining muscle.
For context on how TRT compares to supraphysiological doses, a landmark 1996 study by Bhasin and colleagues gave men 600 mg of testosterone per week, pushing their levels above 2,800 ng/dL. Even without any exercise, those men increased quadriceps size and boosted squat strength by 19% in just 10 weeks. That kind of result is not what TRT produces. Therapeutic doses aim for levels roughly one-third to one-fifth of that, and the muscle gains are correspondingly more modest.
Timeline for Visible Changes
Muscle-related changes from TRT follow a fairly predictable schedule. Lean body mass and muscle strength improvements first become measurable at 12 to 16 weeks. These changes stabilize somewhere between 6 and 12 months, though marginal gains can continue beyond that. Fat loss follows a similar arc, with reductions in body fat detectable by three months and ongoing improvement for up to two years.
Other effects arrive on different timelines. Energy and mood improvements often show up within three to six weeks. Changes in sexual function may take up to six months. Red blood cell production increases noticeably by three months and peaks around nine to twelve months, which is one reason regular blood work matters during treatment.
Training and Protein Still Drive Results
Testosterone creates the hormonal environment for muscle growth, but it doesn’t replace the stimulus. The way testosterone builds muscle is by boosting protein synthesis inside muscle fibers and activating satellite cells, which are essentially repair cells that fuse with damaged muscle fibers to make them larger and stronger. Testosterone also nudges precursor cells toward becoming muscle tissue rather than fat. All of these processes are amplified when you’re actually training hard enough to create the damage that triggers repair.
Protein intake matters too, but more isn’t always better. Diets providing between 1.25 and 3.4 grams of protein per kilogram of body weight per day don’t appear to negatively affect testosterone levels, and the higher end of that range helps preserve lean mass, especially during fat loss. For a 180-pound (82 kg) man, that translates to roughly 100 to 280 grams of protein daily. Going extremely high, above 3.4 g/kg/day, has been associated with lower total testosterone in some analyses, though very few people eat that much protein in practice.
Monitoring and Safety Thresholds
TRT is not a set-it-and-forget-it treatment. Your prescriber will monitor blood work at regular intervals, and two values in particular can flag problems. Hematocrit, which measures the concentration of red blood cells, should stay below 54%. Testosterone stimulates red blood cell production, and if levels climb too high, your blood becomes thicker and the risk of clotting increases. If hematocrit crosses that threshold, therapy is paused until it drops back down, then restarted at a lower dose.
Prostate-specific antigen (PSA) is the other marker to watch. A PSA jump of more than 1.4 ng/mL within the first 12 months, or a confirmed reading above 4 ng/mL at any point, warrants further evaluation. TRT causes a small, expected rise in PSA and prostate volume that typically plateaus within the first year.
It’s also worth noting that TRT is FDA-approved only for men with clinically diagnosed low testosterone tied to a specific medical condition, such as a genetic disorder, chemotherapy-related damage, or a pituitary problem. Low testosterone from aging alone is not an approved indication, though it is frequently treated off-label. Understanding this distinction matters if you’re exploring TRT primarily for physique goals rather than symptom relief.